Literature DB >> 28197859

Imaging the up's and down's of emotion regulation in lifetime depression.

Sina Radke1,2, Felix Hoffstaedter3,4, Leonie Löffler5, Lydia Kogler5,6, Frank Schneider5,7, Jens Blechert8,9, Birgit Derntl5,7,3,6,10,11.   

Abstract

Reappraisal is a particularly effective strategy for influencing emotional experiences, specifically for reducing the impact of negative stimuli. Although depression has repeatedly been linked to dysfunctional behavioral and neural emotion regulation, prefrontal and amygdala engagement seems to vary with clinical characteristics and the specific regulation strategy used. Whereas previous neuroimaging research has focused on down-regulating reactions to emotionally evocative scenes, the current study compared up- and down-regulation in response to angry facial expressions in patients with depression and healthy individuals. During the initial viewing of faces, patients with depression showed hypoactivation particularly in areas implicated in emotion generation, i.e., amygdala, insula and putamen. In contrast, up-regulating negative emotions yielded stronger recruitment of core face processing areas and posterior medial frontal cortex in patients than in controls. However, group differences did not extend to resting-state functional connectivity. Recurrent depression was inversely associated with amygdala activation specifically during down-regulation, but differences in medication status may limit the current findings. Despite a pattern of reduced neural emotional reactivity in mainly medicated patients, their 'successful' recruitment of the regulation network for up-regulation might point toward an effective use of reappraisal when increasing negative emotions. Future studies need to address how patients might benefit from transferring this ability to adaptive goals, such as improving interpersonal emotion regulation.

Entities:  

Keywords:  Depression; Emotion regulation; Facial expression; Reappraisal; fMRI

Mesh:

Year:  2018        PMID: 28197859     DOI: 10.1007/s11682-017-9682-2

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  6 in total

Review 1.  Abnormal neural activities in adults and youths with major depressive disorder during emotional processing: a meta-analysis.

Authors:  Xuqian Li; Junjing Wang
Journal:  Brain Imaging Behav       Date:  2021-04       Impact factor: 3.978

2.  Distinct neural engagement during implicit and explicit regulation of negative stimuli.

Authors:  Jacklynn M Fitzgerald; Kerry L Kinney; K Luan Phan; Heide Klumpp
Journal:  Neuropsychologia       Date:  2018-02-08       Impact factor: 3.139

3.  The regulation of positive and negative emotions through instructed causal attributions in lifetime depression - A functional magnetic resonance imaging study.

Authors:  Leonie A K Loeffler; Sina Radke; Ute Habel; Rastko Ciric; Theodore D Satterthwaite; Frank Schneider; Birgit Derntl
Journal:  Neuroimage Clin       Date:  2018-10-25       Impact factor: 4.881

4.  In search of convergent regional brain abnormality in cognitive emotion regulation: A transdiagnostic neuroimaging meta-analysis.

Authors:  Tina Khodadadifar; Zahra Soltaninejad; Amir Ebneabbasi; Claudia R Eickhoff; Christian Sorg; Thilo Van Eimeren; Kai Vogeley; Mojtaba Zarei; Simon B Eickhoff; Masoud Tahmasian
Journal:  Hum Brain Mapp       Date:  2021-11-26       Impact factor: 5.038

5.  The antidepressant effect of cognitive reappraisal training on individuals cognitively vulnerable to depression: Could cognitive bias be modified through the prefrontal-amygdala circuits?

Authors:  Xiaoxia Wang; Ying He; Zhengzhi Feng
Journal:  Front Hum Neurosci       Date:  2022-08-04       Impact factor: 3.473

6.  Effects of age and gender on neural correlates of emotion imagery.

Authors:  Barbara Tomasino; Eleonora Maggioni; Carolina Bonivento; Maria Nobile; Serena D'Agostini; Filippo Arrigoni; Franco Fabbro; Paolo Brambilla
Journal:  Hum Brain Mapp       Date:  2022-05-12       Impact factor: 5.399

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.